SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Oravetz who wrote (216)12/15/2000 7:30:43 AM
From: Jim Oravetz  Read Replies (1) of 370
 
On November 22, 2000, Vion Pharmaceuticals, Inc. (the "Company") mailed a notice to the holders of its outstanding shares of Class A Convertible Preferred Stock, par value $.01 per share ("Class A Stock"), calling for the redemption of such stocks on December 26, 2000 (the "Redemption Date") at a redemption price of $10.00 per share. As of November 22, 2000, 1,950 shares of Class A Stock were outstanding. The maximum amount of cash that would be required for redemption of the Class A Stock would be $19,500.

A registered holder of Class A Stock shall have the right to convert each share of Class A Stock into 2.777777 shares of the Company's Common Stock, reflecting a current conversion price of $3.60 per share of Common Stock, prior to the Redemption Date. The maximum number of shares of Common Stock which would be issued if all outstanding shares of Class A Stock are converted prior to redemption is 5,421. This right to convert the Class A Stock shall terminate at 5:00 p.m., New York City time, on the Redemption Date. After 5:00 p.m. New York time on the Redemption Date the Class A Stock will no longer be convertible and the holders will only have the right to receive the redemption price.

12/1/00 S-8 filing
Jim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext